Shashi Rajput

1.2k total citations
23 papers, 936 citations indexed

About

Shashi Rajput is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Shashi Rajput has authored 23 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Biomedical Engineering and 7 papers in Biomaterials. Recurrent topics in Shashi Rajput's work include Nanoplatforms for cancer theranostics (7 papers), Nanoparticle-Based Drug Delivery (6 papers) and Nigella sativa pharmacological applications (5 papers). Shashi Rajput is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Nanoparticle-Based Drug Delivery (6 papers) and Nigella sativa pharmacological applications (5 papers). Shashi Rajput collaborates with scholars based in India, United States and Canada. Shashi Rajput's co-authors include Mahitosh Mandal, B. N. Prashanth Kumar, Nagaprasad Puvvada, Siddik Sarkar, Amita Pathak, Paul B. Fisher, Kaushik Dey, Aditya Parekh, Ipsita Pal and Abhijit Mazumdar and has published in prestigious journals such as PLoS ONE, Langmuir and Oncogene.

In The Last Decade

Shashi Rajput

23 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shashi Rajput India 19 322 210 198 171 140 23 936
B. N. Prashanth Kumar India 19 435 1.4× 343 1.6× 201 1.0× 330 1.9× 409 2.9× 25 1.4k
Swatilekha Ghosh India 12 305 0.9× 98 0.5× 131 0.7× 126 0.7× 59 0.4× 22 659
Manisha Ahir India 14 246 0.8× 158 0.8× 110 0.6× 198 1.2× 152 1.1× 21 692
Ding Qu China 22 512 1.6× 250 1.2× 137 0.7× 319 1.9× 128 0.9× 50 1.2k
Shakti Ranjan Satapathy India 22 606 1.9× 117 0.6× 61 0.3× 76 0.4× 118 0.8× 45 1.2k
Ruoqiu Fu China 15 498 1.5× 182 0.9× 65 0.3× 270 1.6× 69 0.5× 26 1.2k
Kang Fang China 22 603 1.9× 229 1.1× 45 0.2× 122 0.7× 152 1.1× 100 1.2k
Rupa Sanyal India 7 449 1.4× 218 1.0× 60 0.3× 185 1.1× 112 0.8× 14 1.1k
Abdulwahab Noorwali Saudi Arabia 9 128 0.4× 83 0.4× 106 0.5× 110 0.6× 55 0.4× 22 482
Ziyu Jiang China 16 354 1.1× 127 0.6× 58 0.3× 77 0.5× 173 1.2× 37 829

Countries citing papers authored by Shashi Rajput

Since Specialization
Citations

This map shows the geographic impact of Shashi Rajput's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashi Rajput with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashi Rajput more than expected).

Fields of papers citing papers by Shashi Rajput

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shashi Rajput. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashi Rajput. The network helps show where Shashi Rajput may publish in the future.

Co-authorship network of co-authors of Shashi Rajput

This figure shows the co-authorship network connecting the top 25 collaborators of Shashi Rajput. A scholar is included among the top collaborators of Shashi Rajput based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shashi Rajput. Shashi Rajput is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, B. N. Prashanth, Nagaprasad Puvvada, Shashi Rajput, et al.. (2018). Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica–Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer. Molecular Pharmaceutics. 15(7). 2698–2713. 27 indexed citations
2.
Sarkar, Siddik, Suraj Konar, Nagaprasad Puvvada, et al.. (2017). Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment. Langmuir. 33(31). 7649–7659. 36 indexed citations
3.
Kumar, B. N. Prashanth, Shashi Rajput, Rashmi Bharti, Sheetal Parida, & Mahitosh Mandal. (2015). BI2536 – A PLK inhibitor augments paclitaxel efficacy in suppressing tamoxifen induced senescence and resistance in breast cancer cells. Biomedicine & Pharmacotherapy. 74. 124–132. 21 indexed citations
4.
Bharti, Rashmi, Goutam Dey, Probir Kumar Ojha, et al.. (2015). Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer. Oncogene. 35(30). 3965–3975. 63 indexed citations
5.
Puvvada, Nagaprasad, Shashi Rajput, B. N. Prashanth Kumar, et al.. (2015). Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression. Scientific Reports. 5(1). 11760–11760. 72 indexed citations
6.
Dey, Kaushik, Ipsita Pal, Rashmi Bharti, et al.. (2015). Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach. Tumor Biology. 36(12). 9829–9837. 18 indexed citations
7.
Rajput, Shashi, Nagaprasad Puvvada, B. N. Prashanth Kumar, et al.. (2015). Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold Niosomes. Molecular Pharmaceutics. 12(12). 4214–4225. 62 indexed citations
8.
Rajput, Shashi, B. N. Prashanth Kumar, Payel Banik, Sheetal Parida, & Mahitosh Mandal. (2014). Thymoquinone Restores Radiation‐Induced TGF‐β Expression and Abrogates EMT in Chemoradiotherapy of Breast Cancer Cells. Journal of Cellular Physiology. 230(3). 620–629. 45 indexed citations
9.
Pal, Ipsita, Siddik Sarkar, Shashi Rajput, et al.. (2014). BI-69A11 enhances susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt. British Journal of Cancer. 111(1). 101–111. 10 indexed citations
10.
Rajput, Shashi, B. N. Prashanth Kumar, Siddik Sarkar, et al.. (2013). Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer. PLoS ONE. 8(4). e61342–e61342. 104 indexed citations
11.
Sarkar, Siddik, Shashi Rajput, Amit Kumar Tripathi, & Mahitosh Mandal. (2013). Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells. Molecular Cancer. 12(1). 122–122. 18 indexed citations
12.
Pradhan, Rangadhar, Shashi Rajput, Mahitosh Mandal, Analava Mitra, & Soumen Das. (2013). Frequency dependent impedimetric cytotoxic evaluation of anticancer drug on breast cancer cell. Biosensors and Bioelectronics. 55. 44–50. 27 indexed citations
13.
Pradhan, Rangadhar, Shashi Rajput, Mahitosh Mandal, Analava Mitra, & Soumen Das. (2013). Electric cell–substrate impedance sensing technique to monitor cellular behaviours of cancer cells. RSC Advances. 4(19). 9432–9432. 19 indexed citations
14.
Rajput, Shashi, B. N. Prashanth Kumar, Kaushik Dey, et al.. (2013). Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Life Sciences. 93(21). 783–790. 108 indexed citations
15.
Sambath, Karthik, Nagaprasad Puvvada, B. N. Prashanth Kumar, et al.. (2013). Photoresponsive Coumarin-Tethered Multifunctional Magnetic Nanoparticles for Release of Anticancer Drug. ACS Applied Materials & Interfaces. 5(11). 5232–5238. 79 indexed citations
16.
Puvvada, Nagaprasad, Shashi Rajput, B. N. Prashanth Kumar, Mahitosh Mandal, & Amita Pathak. (2013). Exploring the fluorescence switching phenomenon of curcumin encapsulated niosomes: in vitro real time monitoring of curcumin release to cancer cells. RSC Advances. 3(8). 2553–2553. 25 indexed citations
17.
Kumar, B. N. Prashanth, Shashi Rajput, Kaushik Dey, et al.. (2013). Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. BMC Cancer. 13(1). 60 indexed citations
18.
Rajput, Shashi, Kaushik Dey, Koushik Sen, et al.. (2012). 201 Combinatorial Effect of ZD6474 and Thymoquinone Inhibits Src Mediated ERK-1/2/STAT3 Signalling and Renders Antimetastasis in Breast Cancer. European Journal of Cancer. 48. 61–61. 1 indexed citations
19.
Rajput, Shashi & Mahitosh Mandal. (2011). Antitumor promoting potential of selected phytochemicals derived from spices. European Journal of Cancer Prevention. 21(2). 205–215. 70 indexed citations
20.
Sarkar, Siddik, Subhasis Das, Shashi Rajput, et al.. (2011). Expressions of CK-19, NF-kappaB, E-cadherin, beta-catenin and EGFR as diagnostic and prognostic markers by immunohistochemical analysis in thyroid carcinoma.. PubMed. 9(3). 187–99. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026